Second‐generation drug‐eluting stents versus drug‐coated balloons for the treatment of coronary in‐stent restenosis: A systematic review and meta‐analysis

Damianos G. Kokkinidis(Memorial Hospital of South Bend), Ehrin J. Armstrong(University of Denver), Joo Myung Lee(Samsung Medical Center), Stephen W. Waldo(United States Department of Veterans Affairs), Andrew Prouse(Denver VA Medical Center), Seth J. Avner(Jacobi Medical Center)

Catheterization and Cardiovascular Interventions

October 10, 2017

10.1002/ccd.27359

Cited by 12

Related Papers

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York

|Metabolism|2020|901

Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

|JAMA Cardiology|2019|418

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease

|Journal of the American Heart Association|2014|243

Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb Ischemia

|Journal of the American College of Cardiology|2013|188

Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent Thrombosis

|JACC: Cardiovascular Interventions|2012|182